Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARUMA RESOURCES LIMITED Proxy Solicitation & Information Statement 2025

May 14, 2025

64273_rns_2025-05-14_faf2912f-d91d-4d91-9f6f-417a142f0dd6.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

ARUMA RESOURCES LIMITED ACN 141 335 364 NOTICE OF GENERAL MEETING

Notice is given that the Meeting will be held at:

TIME : 10:15am (AEST) DATE : 16 June 2025 PLACE : Room 26L – Wynyard Level 26 1 Bligh Street SYDNEY NSW 2000

The business of the Meeting affects your shareholding and your vote is important.

This Notice should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their professional advisers prior to voting.

The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders at 5:00pm (AEST) on 14 June 2025.

BU S IN E S S O F T HE ME E T ING

AGENDA

1. RESOLUTION 1 – RATIFICATION OF PRIOR ISSUE OF TRANCHE 1 PLACEMENT SHARES – LISTING RULE 7.1

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of 22,205,817 Placement Shares on the terms and conditions set out in the Explanatory Statement.”

2. RESOLUTION 2 – RATIFICATION OF PRIOR ISSUE OF TRANCHE 1 PLACEMENT SHARES – LISTING RULE 7.1A

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of 33,308,725 Placement Shares on the terms and conditions set out in the Explanatory Statement.”

3. RESOLUTION 3 – APPROVAL TO ISSUE TRANCHE 2 PLACEMENT SHARES

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given for the Company to issue up to 44,485,458 Placement Shares on the terms and conditions set out in the Explanatory Statement.”

4. RESOLUTION 4 – APPROVAL TO ISSUE PLACEMENT OPTIONS

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given for the Company to issue up to 100,000,000 Placement Options on the terms and conditions set out in the Explanatory Statement.

5. RESOLUTION 5 – APPROVAL FOR DIRECTOR PARTICIPATION IN PLACEMENT – MR JAMES MOSES

To consider and, if thought fit, to pass the following resolution as an ordinary resolution :

“That, for the purposes of section 195(4) of the Corporations Act, Listing Rule 10.11 and for all other purposes, approval is given for the Company to issue up to 4,705,882 Placement Shares and 4,705,882 Placement Options to Mr James Moses (or his nominee(s)) on the terms and conditions set out in the Explanatory Statement.”

6. RESOLUTION 6 – APPROVAL FOR DIRECTOR PARTICIPATION IN PLACEMENT – MR BRETT SMITH

To consider and, if thought fit, to pass the following resolution as an ordinary resolution :

“That, for the purposes of section 195(4) of the Corporations Act, Listing Rule 10.11 and for all other purposes, approval is given for the Company to issue up to 1,176,471 Placement Shares and 1,176,471 Placement Options to Mr Brett Smith (or his nominee(s)) on the terms and conditions set out in the Explanatory Statement.”

1

7. RESOLUTION 7 – APPROVAL TO ISSUE OPTIONS TO GBA CAPITAL

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given for the Company to issue 15,000,000 Lead Manager Options to GBA Capital on the terms and conditions set out in the Explanatory Statement.”

8. RESOLUTION 8 – APPROVAL TO ISSUE PERFORMANCE RIGHTS – MR GRANT FERGUSON

“That, for the purposes of Listing Rule 10.11 and for all other purposes, approval is given for the Company to issue 8,865,000 Performance Rights to Mr Grant Ferguson (or his nominee(s)) on the terms and conditions set out in the Explanatory Statement.”

Dated: 12 May 2025

By Order of the Board

2

Voting Prohibition Statements

Resolution 8 – Approval to Issue
Performance Rights – Mr Grant
Ferguson
A person appointed as a proxy must not vote, on the basis of that appointment,
on this Resolution if:
(a)
the proxy is either:
(i)
a member of the Key Management Personnel; or
(ii)
a Closely Related Party of such a member; and
(a)
the appointment does not specify the way the proxy is to vote on this
Resolution.
However, the above prohibition does not apply if:
(a)
the proxy is the Chair; and
(b)
the appointment expressly authorises the Chair to exercise the proxy
even though this Resolution is connected directly or indirectly with
remuneration of a member of the KeyManagement Personnel.

Voting Exclusion Statements

In accordance with Listing Rule 14.11, the Company will disregard any votes cast in favour of the Resolution set out below by or on behalf of the following persons:

Resolution 1 – Ratification of
prior issue of Tranche 1
Placement Shares – Listing Rule
7.1
A person who participated in the issue or an associate of that person or those
persons.
Resolution 2 – Ratification of
prior issue of Tranche 1
Placement Shares – Listing Rule
7.1A
A person who participated in the issue or an associate of that person or those
persons.
Resolution 3 – Approval to
issue Tranche 2 Placement
Shares
A person who is expected to participate in, or who will obtain a material benefit
as a result of, the proposed issue (except a benefit solely by reason of being a
holder of ordinary securities in the Company) or an associate of that person (or
thosepersons).
Resolution 4 – Approval to
issue Placement Options
A person or any other person who is expected to participate in, or who will obtain
a material benefit as a result of, the proposed issue (except a benefit solely by
reason of being a holder of ordinary securities in the Company) or an associate
of thatperson(or thosepersons).
Resolution 5 – Approval for
Director Participation in
Placement – Mr James Moses
Mr James Moses (or his nominee(s)) and any other person who will obtain a
material benefit as a result of the issue of the securities (except a benefit solely by
reason of being a holder of ordinary securities in the Company) or an associate
of thatperson or thosepersons.
Resolution 6 – Approval for
Director Participation in
Placement – Mr Brett Smith
Mr Brett Smith (or his nominee(s)) and any other person who will obtain a material
benefit as a result of the issue of the securities (except a benefit solely by reason
of being a holder of ordinary securities in the Company) or an associate of that
person or thosepersons.
Resolution 7 – Approval to
Issue Options to GBA Capital
GBA Capital or any other person who is expected to participate in, or who will
obtain a material benefit as a result of, the proposed issue (except a benefit solely
by reason of being a holder of ordinary securities in the Company) or an
associate of thatperson(or thosepersons).
Resolution 8 – Approval to
Issue Performance Rights – Mr
Grant Ferguson
Mr Grant Ferguson (or his nominee(s)) and any other person who will obtain a
material benefit as a result of the issue of the securities (except a benefit solely by
reason of being a holder of ordinary securities in the Company) or an associate
of thatperson or thosepersons.

However, this does not apply to a vote cast in favour of the Resolution by:

  • (a) a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with the directions given to the proxy or attorney to vote on the Resolution in that way; or

  • (b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

3

Voting by proxy

To vote by proxy, please complete and sign the enclosed Proxy Form and return by the time and in accordance with the instructions set out on the Proxy Form.

In accordance with section 249L of the Corporations Act, Shareholders are advised that:

  • each Shareholder has a right to appoint a proxy;

  • the proxy need not be a Shareholder of the Company; and

  • a Shareholder who is entitled to cast two or more votes may appoint two proxies and may specify the proportion or number of votes each proxy is appointed to exercise. If the Shareholder appoints two proxies and the appointment does not specify the proportion or number of the member’s votes, then in accordance with section 249X(3) of the Corporations Act, each proxy may exercise one-half of the votes.

Shareholders and their proxies should be aware that:

  • if proxy holders vote, they must cast all directed proxies as directed; and

  • any directed proxies which are not voted will automatically default to the Chair, who must vote the proxies as directed.

Voting in person

To vote in person, attend the Meeting at the time, date and place set out above.

You may still attend the Meeting and vote in person even if you have appointed a proxy. If you have previously submitted a Proxy Form, your attendance will not revoke your proxy appointment unless you actually vote at the Meeting for which the proxy is proposed to be used, in which case, the proxy’s appointment is deemed to be revoked with respect to voting on that Resolution.

Should you wish to discuss the matters in this Notice please do not hesitate to contact the Company Secretary on +61 8 9321 0177.

4

E XPL A N A TO RY S T AT E MEN T

This Explanatory Statement has been prepared to provide information which the Directors believe to be material to Shareholders in deciding whether or not to pass the Resolutions.

1. BACKGROUND TO RESOLUTIONS 1 TO 7

1.1 General

On 16 April 2025, the Company announced that it received firm commitments from sophisticated and professional investors to raise up to approximately $900,000 (before costs) ( Placement ) through the issue of an aggregate of 105,882,353 fully paid ordinary Shares at an issue price of $0.0085 per Share ( Placement Shares ), together with one free attaching unlisted Option for each Share subscribed for and issued, exercisable at $0.017 each on or before 30 June 2028 ( Placement Options ).

The Placement is to be completed in two tranches:

  • (a) 55,514,542 Placement Shares, which were issued on 24 April 2025, comprising:

  • (i) 22,205,817 Placement Shares issued pursuant to the Company’s existing placement capacity under Listing Rule 7.1 (being the Shares the subject of Resolution 1); and

  • (ii) 33,308,725 Placement Shares issued pursuant to the Company’s existing placement capacity under Listing Rule 7.1A (being the Shares the subject of Resolution 2)

(together, Tranche 1 ),

  • (b) up to 44,485,458 Placement Shares to unrelated participants in the Placement, subject to shareholder approval pursuant to Resolution 3 ( Tranche 2 );

  • (c) up to 100,000,000 Placement Options to unrelated participants in the Placement subject to shareholder approval pursuant to Resolution 4; and

  • (d) an aggregate of up to 5,882,353 Placement Shares and up to 5,882,353 Placement Options to the Directors participating in the Placement, comprising:

  • (i) up to 4,705,882 Placement Shares and up to 4,705,882 Placement Options to Mr James Moses subject to shareholder approval pursuant to Resolution 5; and

  • (ii) up to 1,176,471 Placement Shares and up to 1,176,471 Placement Options to Mr Brett Smith subject to shareholder approval pursuant to Resolution 6.

1.2 Lead Manager

The Company engaged the services of GBA Capital Pty Ltd (ACN 643 039 123) ( GBA Capital ) to act as lead manager to the Placement pursuant to a lead manager mandate dated 7 April 2025 ( Mandate ).

Pursuant to the Mandate, in consideration for lead manager services provided, the Company agreed to:

  • (a) pay GBA Capital a capital raising fee of 6% plus GST of the total funds raised under the Placement; and

  • (b) subject to Shareholder approval, issue to GBA Capital (or its nominee(s)) 15,000,000 Options on the same terms and conditions as the Placement Options ( Lead Manager Options ) (the subject of Resolution 7).

The Mandate contains terms which are standard for an agreement of this type.

5

1.3 Use of funds

Funds raised from the Placement are intended to be used to fund the Company’s exploration and drilling at existing projects, as well as applied towards the costs of the Placement and general working capital.

2. RESOLUTIONS 1 AND 2 – RATIFICATION OF PRIOR ISSUE OF TRANCHE 1 PLACEMENT SHARES – LISTING RULES 7.1 AND 7.1A

2.1 General

Resolutions 1 and 2 seek Shareholder ratification for the purposes of Listing Rule 7.4 for the issue of an aggregate of 55,514,542 Placement Shares at an issue price of $0.0085 each to raise $471,873 (before costs).

22,205,817 Placement Shares were issued pursuant to the Company’s capacity under Listing Rule 7.1 (being, the subject of Resolution 1) and 33,308,725 Placement Shares were issued on 24 April 2025 pursuant to the Company’s placement capacity under Listing Rule 7.1A.

2.2 Listing Rules 7.1 and 7.1A

Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of equity securities that a listed company can issue without the approval of its shareholders over any 12 month period to 15% of the fully paid ordinary securities it had on issue at the start of that 12 month period.

Under Listing Rule 7.1A however, an Eligible Entity can seek approval from its members, by way of a special resolution passed at its annual general meeting, to increase this 15% limit by an extra 10% to 25%. The Company obtained this approval at its annual general meeting held on 29 November 2024.

The issue does not fit within any of the exceptions set out in Listing Rule 7.2 and, as it has not yet been approved by Shareholders, it effectively uses up part of the 25% limit in Listing Rules 7.1 and 7.1A, reducing the Company’s capacity to issue further equity securities without Shareholder approval under Listing Rule 7.1 and 7.1A for the 12 month period following the date of the issue.

2.3 Listing Rule 7.4

Listing Rule 7.4 allows the shareholders of a listed company to approve an issue of equity securities after it has been made or agreed to be made. If they do, the issue is taken to have been approved under Listing Rule 7.1 and so does not reduce the company’s capacity to issue further equity securities without shareholder approval under that rule.

The Company wishes to retain as much flexibility as possible to issue additional equity securities in the future without having to obtain Shareholder approval for such issues under Listing Rule 7.1. Accordingly, the Company is seeking Shareholder ratification pursuant to Listing Rule 7.4 for the issue.

2.4 Technical information required by Listing Rule 14.1A

If Resolutions 1 and 2 are passed, the issue will be excluded in calculating the Company’s combined 25% limit in Listing Rules 7.1 and 7.1A, effectively increasing the number of equity securities the Company can issue without Shareholder approval over the 12 month period following the date of the issue.

If Resolutions 1 and 2 are not passed, the issue will be included in calculating the Company’s combined 25% limit in Listing Rules 7.1 and 7.1A, effectively decreasing the number of equity securities the Company can issue without Shareholder approval over the 12 month period following the date of the issue.

6

2.5 Technical information required by Listing Rule 7.5

REQUIRED INFORMATION DETAILS
Names of persons to whom
Securities were issued or the
basis on which those persons
were identified/selected
Professional and sophisticated investors who were identified
through a bookbuild process, which involved GBA Capital
seeking expressions of interest to participate in the capital
raising from non-related parties of the Company.
The Company confirms that no Material Persons were issued
more than 1% of the issued capital of the Company.
Number and class of
Securities issued
55,514,542 Shares were issued on the following basis:
(a)
22,205,817 Placement Shares were issued under
Listing Rule 7.1 (ratification of which is sought
under Resolution 1); and
(b)
33,308,725 Placement Shares issued pursuant to
Listing Rule 7.1A (ratification of which is sought
under Resolution 2).
Terms of Securities The Placement Shares were fully paid ordinary shares in the
capital of the Company issued on the same terms and
conditions as the Company’s existing Shares.
Date(s) on or by which the
Securities were issued
24 April 2025.
Price or other consideration
the Company received for
the Securities
$0.0085 per Placement Share for Placement Shares issued
pursuant to Listing Rule 7.1 and Listing Rule 7.1A.
Purpose of the issue,
including the intended use of
any funds raised by the issue
Refer to Section 1.3 for details of the proposed use of funds.
Summary of material terms of
agreement to issue
The Securities were not issued under an agreement.
Voting Exclusion Statement A voting exclusion statement applies to Resolutions 1 and 2.
Compliance The issue did not breach Listing Rule 7.1.

3. RESOLUTION 3 – APPROVAL TO ISSUE TRANCHE 2 PLACEMENT SHARES

3.1 General

Resolution 3 seeks Shareholder approval for the purposes of Listing Rule 7.1 for the issue of up to 44,485,458 Tranche 2 Placement Shares to professional and sophisticated investors at an issue price of $0.0085 per Share to raise up to $378,126 (before costs).

A summary of Listing Rule 7.1 is set out in Section 2.2 above.

The proposed issue does not fall within any of the exceptions set out in Listing Rule 7.2 and exceeds the 15% limit in Listing Rule 7.1. It therefore requires the approval of Shareholders under Listing Rule 7.1.

3.2 Technical information required by Listing Rule 14.1A

If Resolution 3 is passed, the Company will be able to proceed with the issue. In addition, the issue will be excluded from the calculation of the number of equity securities that the Company can issue without Shareholder approval under Listing Rule 7.1.

If Resolution 3 is not passed, the Company will not be able to proceed with the issue.

7

3.3 Technical information required by Listing Rule 7.3

REQUIRED INFORMATION DETAILS
Names of persons to whom
Securities will be issued or the
basis on which those persons
were or will be
identified/selected
Professional and sophisticated investors who will be
identified through a bookbuild process, which will involve
GBA Capital seeking expressions of interest to participate in
the capital raising from non-related parties of the Company.
The Company confirms that no Material Persons will be
issued more than 1% of the issued capital of the Company.
Number of Securities and
class to be issued
Up to 44,485,458 Tranche 2 Placement Shares will be issued.
Terms of Securities The Tranche 2 Placement Shares will be fully paid ordinary
shares in the capital of the Company issued on the same
terms and conditions as the Company’s existing Shares.
Date(s) on or by which the
Securities will be issued
The Company expects to issue the Tranche 2 Placement
Shares within 5 Business Days of the Meeting. In any event,
the Company will not issue any Tranche 2 Placement Shares
later than three months after the date of the Meeting (or
such later date to the extent permitted by any ASX waiver
or modification of the Listing Rules).
Price or other consideration
the Company will receive for
the Securities
$0.0085 per Tranche 2 Placement Share.
Purpose of the issue,
including the intended use of
any funds raised by the issue
Refer to Section 1.3 for details of the proposed use of funds.
Summary of material terms of
agreement to issue
The Tranche 2 Placement Shares were not issued under an
agreement.
Voting exclusion statement A voting exclusion statement applies to this Resolution.

4. RESOLUTION 4 – APPROVAL TO ISSUE PLACEMENT OPTIONS

4.1 General

As summarised in Section 1.1 above, Resolution 4 seeks Shareholder approval for the purposes of Listing Rule 7.1 for the issue of up to 100,000,000 free attaching Placement Options to unrelated participants in the Placement.

A summary of Listing Rule 7.1 is set out in Section 2.2 above.

The proposed issue does not fall within any of the exceptions set out in Listing Rule 7.2 and exceeds the 15% limit in Listing Rule 7.1. It therefore requires the approval of Shareholders under Listing Rule 7.1.

4.2 Technical information required by Listing Rule 14.1A

If Resolution 4 is passed, the Company will be able to proceed with the issue. In addition, the issue will be excluded from the calculation of the number of equity securities that the Company can issue without Shareholder approval under Listing Rule 7.1.

If Resolution 4 is not passed, the Company will not be able to proceed with the issue.

  • 4.3 Technical information required by Listing Rule 7.3
REQUIRED INFORMATION DETAILS
Names of persons to whom
Securities will be issued or the
basis on which those persons
were or will be
identified/selected
Professional and sophisticated investors who were identified
through a bookbuild process, which involved GBA Capital

8

REQUIRED INFORMATION DETAILS
seeking expressions of interest to participate in the capital
raising from non-related parties of the Company.
The Company confirms that no Material Persons were issued
more than 1% of the issued capital of the Company.
Number of Securities and
class to be issued
Up to 100,000,000 Placement Options will be issued.
Terms of Securities The Placement Options will be issued on the terms and
conditions set out in Schedule 1.
Date(s) on or by which the
Securities will be issued
The Company expects to issue the Placement Options
within 5 Business Days of the Meeting. In any event, the
Company will not issue any Placement Options later than
three months after the date of the Meeting (or such later
date to the extent permitted by any ASX waiver or
modification of the Listing Rules).
Price or other consideration
the Company will receive for
the Securities
The Placement Options will be issued free attaching on a 1:1
basis with Placement Shares. No funds will be raised through
the issue of the Placement Options.
Purpose of the issue,
including the intended use of
any funds raised by the issue
Refer to Section 1.3 for details of the proposed use of funds.
Summary of material terms of
agreement to issue
The Placement Options were not issued under an
agreement.
Voting exclusion statement A voting exclusion statement applies to this Resolution.

5. RESOLUTIONS 5 AND 6 – APPROVAL FOR DIRECTOR PARTICIPATION IN PLACEMENT – MR JAMES MOSES AND MR BRETT SMITH

5.1 General

Resolutions 5 and 6 seek Shareholder approval for the purposes of section 195(4) of the Corporations Act and Listing Rule 10.11 for the issue of up to an aggregate of 5,882,353 Placement Shares and 5,882,353 Placement Options to Mr James Moses and Mr Brett Smith (or their nominee(s)) on the terms and conditions set out below to enable the Directors to participate in the Company’s Placement on the same terms as unrelated participants ( Participation ).

Further details in respect of the intended Participation of the Directors are set out in the table below.

RECIPIENT PARTICIPATION PARTICIPATION PARTICIPATION
QUANTUM
RESOLUTION
PLACEMENT
SHARES
PLACEMENT FUNDS RAISED
OPTIONS
Mr James Moses 5 4,705,882 4,705,882 $40,000
Mr Brett Smith 6 1,176,471 1,176,471 $10,000
TOTAL 5,882,353 5,882,353 $50,000

5.2 Chapter 2E of the Corporations Act

Chapter 2E of the Corporations Act requires that for a public company, or an entity that the public company controls, to give a financial benefit to a related party of the public company, the public company or entity must:

(a) obtain the approval of the public company’s members in the manner set out in sections 217 to 227 of the Corporations Act; and

9

(b) give the benefit within 15 months following such approval,

unless the giving of the financial benefit falls within an exception set out in sections 210 to 216 of the Corporations Act.

The Participation will constitute giving a financial benefit and each of the proposed recipients is a related party of the Company by virtue of being a Director.

The Directors (other than Mr Moses who has a material personal interest in Resolution 5) consider that Shareholder approval pursuant to Chapter 2E of the Corporations Act is not required in respect of Resolution 5 because the Securities will be issued to Mr Moses on the same terms as Securities offered to unrelated participants in the Placement and as such the giving of the financial benefit is on arm’s length terms.

The Directors (other than Mr Smith who has a material personal interest in Resolution 6) consider that Shareholder approval pursuant to Chapter 2E of the Corporations Act is not required in respect of Resolution 6 because the Securities will be issued to Mr Smith on the same terms as Securities offered to unrelated participants in the Placement and as such the giving of the financial benefit is on arm’s length terms.

5.3 Section 195(4) of the Corporations Act

Section 195 of the Corporations Act provides that a director of a public company may not vote or be present during meetings of directors when matters in which that director holds a “material personal interest” are being considered, except in certain limited circumstances. Section 195(4) relevantly provides that if there are not enough directors to form a quorum for a directors meeting because of this restriction, one or more of the directors may call a general meeting and the general meeting may pass a resolution to deal with the matter.

It might be argued (but it is neither conceded nor, indeed, is it thought by the Board to be the case) that two of the three of the Directors comprising the Board have a material personal interest in the outcome of Resolutions 5 and 6. If Mr Moses and Mr Smith do have such an interest, then a quorum could not be formed to consider the matters contemplated by Resolutions 5 and 6 at Board level.

Accordingly, for the avoidance of any doubt, and for the purpose of transparency and best practice corporate governance, the Company also seeks Shareholder approval for Resolutions 5 and 6 for the purposes of section 195(4) of the Corporations Act in respect of the reliance on the arm’s length terms exception and the decision not to seek Shareholder approval under Chapter 2E of the Corporations Act.

5.4

Listing Rule 10.11

Listing Rule 10.11 provides that unless one of the exceptions in Listing Rule 10.12 applies, a listed company must not issue or agree to issue equity securities to:

  • 10.11.1 a related party;

  • 10.11.2 a person who is, or was at any time in the 6 months before the issue or agreement, a substantial (30%+) holder in the company;

  • 10.11.3 a person who is, or was at any time in the 6 months before the issue or agreement, a substantial (10%+) holder in the company and who has nominated a director to the board of the company pursuant to a relevant agreement which gives them a right or expectation to do so;

  • 10.11.4 an associate of a person referred to in Listing Rules 10.11.1 to 10.11.3; or

  • 10.11.5 a person whose relationship with the company or a person referred to in Listing Rules 10.11.1 to 10.11.4 is such that, in ASX’s opinion, the issue or agreement should be approved by its shareholders,

unless it obtains the approval of its shareholders.

The Participation falls within Listing Rule 10.11.1 and does not fall within any of the exceptions in Listing Rule 10.12. It therefore requires the approval of Shareholders under Listing Rule 10.11.

10

5.5 Technical information required by Listing Rule 14.1A

If Resolutions 5 and 6 are passed, the Company will be able to proceed with the issue within one month after the date of the Meeting (or such later date as permitted by any ASX waiver or modification of the Listing Rules). As approval pursuant to Listing Rule 7.1 is not required for the issue (because approval is being obtained under Listing Rule 10.11), the issue will not use up any of the Company’s 15% annual placement capacity.

If Resolutions 5 and 6 are not passed, the Company will not be able to proceed with the issue.

5.6 Technical Information required by Listing Rule 10.13

REQUIRED INFORMATION DETAILS
Name of the persons to whom
Securities will be issued
The proposed recipients of the Securities are set out in
Section 5.1 above.
Categorisation under Listing
Rule 10.11
Each of the proposed recipients falls within the category set
out in Listing Rule 10.11.1 as they are a related party of the
Company by virtue of being a Director.
Any nominee(s) of the proposed recipients who receive
Securities may constitute ‘associates’ for the purposes of
Listing Rule 10.11.4.
Number of Securities and
class to be issued
The maximum number of Securities to be issued (being the
nature of the financial benefit proposed to be given) and
the allocation between the recipients is set out in the table
included at Section 5.1 above.
Terms of Securities The Placement Shares will be fully paid ordinary shares in the
capital of the Company issued on the same terms and
conditions as the Company’s existing Shares.
The Placement Options will be issued on the terms and
conditions set out in Schedule 1.
Date(s) on or by which the
Securities will be issued
The Company expects to issue the Securities within 5
Business Days of the Meeting. In any event, the Company
will not issue any Securities later than one month after the
date of the Meeting (or such later date to the extent
permitted by any ASX waiver or modification of the Listing
Rules).
Price or other consideration
the Company will receive for
the Securities
$0.0085 per Placement Share and nil per Placement Option
as the Placement Options will be issued free attaching with
the Placement Shares on a 1:1 basis.
Purpose of the issue,
including the intended use of
any funds raised by the issue
Refer to Section 1.3 for details of the proposed use of funds.
Consideration of type and
quantum of Security to be
issued
The quantum of Securities to be offered under the capital
raising, the ratio of Placement Shares and Placement
Options, the terms of the Placement Options and the pricing
of the Placement Shares was determined in conjunction
with GBA Capital. The recipients are seeking to participate
in the Placement on the same terms as the unrelated
institutional, professional and sophisticated investors who
took part in the Placement.
It is not considered that there are any significant opportunity
costs to the Company or benefits foregone by the
Company in issuing the Securities on the terms proposed
and the issue of the Securities is not intended to remunerate
or incentivise the Directors.
Summary of material terms of
agreement to issue
The Securities were not issued under an agreement.

11

REQUIRED INFORMATION DETAILS

Voting exclusion statements Voting exclusion statements apply to Resolutions 5 and 6.

6. RESOLUTION 7 – APPROVAL TO ISSUE OPTIONS TO GBA CAPITAL

6.1 General

This Resolution seeks Shareholder approval for the purposes of Listing Rule 7.1 for the issue of up to 15,000,000 Lead Manager Options in consideration for lead manager services provided by GBA Capital.

A summary of Listing Rule 7.1 is set out in Section 2.2 above.

The proposed issue falls within exception 17 of Listing Rule 7.2. It therefore requires the approval of Shareholders under Listing Rule 7.1.

6.2 Technical information required by Listing Rule 14.1A

If Resolution 7 is passed, the Company will be able to proceed with the issue. In addition, the issue will be excluded from the calculation of the number of equity securities that the Company can issue without Shareholder approval under Listing Rule 7.1.

If Resolution 7 is not passed, the Company will not be able to proceed with the issue.

6.3 Technical information required by Listing Rule 7.3

REQUIRED INFORMATION DETAILS
Names of persons to whom
Securities will be issued or the
basis on which those persons
were or will be
identified/selected
GBA Capital (or its nominee(s)).
Number of Securities and
class to be issued
15,000,000 Lead Manager Options will be issued.
Terms of Securities The Lead Manager Options will be issued on the terms and
conditions set out in Schedule 1.
Date(s) on or by which the
Securities will be issued
The Company expects to issue the Lead Manager Options
within 5 Business Days of the Meeting. In any event, the
Company will not issue any Lead Manager Options later
than three months after the date of the Meeting (or such
later date to the extent permitted by any ASX waiver or
modification of the Listing Rules).
Price or other consideration
the Company will receive for
the Securities
The Lead Manager Options will be issued at a nil issue price,
in consideration for lead manager services provided by GBA
Capital.
Purpose of the issue,
including the intended use of
any funds raised by the issue
The purpose of the issue is to satisfy the Company’s
obligations under the Mandate.
Summary of material terms of
agreement to issue
The Lead Manager Options are being issued under the
Mandate, a summary of the material terms of which is set
out in Section 1.2.
Voting exclusion statement A voting exclusion statement applies to this Resolution.

7. RESOLUTION 8 – APPROVAL TO ISSUE PERFORMANCE RIGHTS – MR GRANT FERGUSON

7.1 General

This Resolution seeks Shareholder approval for the purposes of Listing Rule 10.11 for the issue of 8,865,000 Performance Rights to Mr Grant Ferguson (or his nominee(s)) on the terms and conditions set out in Schedule 2.

12

Further details in respect of the Performance Rights proposed to be issued are set out in the table below.

CLASS QUANTUM VESTING CONDITION
A 2,416,585 The Class A Performance Rights shall vest on:
(a)
a Program for Environmental Protection and Rehabilitation
(PEPR) in respect of initial drilling activities at the Wilan
Project (EL 6819 & EL 6870), in South Australia becomes
approved; and
(b)
the Company obtaining any and all necessary approvals
for the purposes of the relevant sections of the_Mining Act_
1971(South Australia) to conduct initial drilling activities.
B 3,288,915 The Class B Performance Rights shall vest on:
(a)
the Company announcing to the ASX an aggregate
drilling intercept in one drill-hole of at least 3m at >600ppm
U308or at least 20m at >0.8% Cu or metals equivalent at
one of the projects:
(i)
Fiery Creek (EPM 27879);
(ii)
Bortala (EPM 28271); or
(iii)
Wilan (EL 6819 & EL 6870); or
(b)
the Company announcing to the ASX drilling intercepts in
two or more drill-holes of 2m at 3g/t Au or metals
equivalent from any one of the Company’s projects.
C 3,159,500 The Class C Performance Rights shall vest upon the release of an ASX
announcement by the Company of the completion of an
acquisition of a material project which demonstrates evidence, to
the Board’s satisfaction acting reasonably, of existing mineralisation
supported by previous exploration results.

7.2 Chapter 2E of the Corporations Act

A summary of Chapter 2E of the Corporations Act is set out in Section 5.2 above.

The issue constitutes giving a financial benefit and Mr Grant Ferguson is a related party of the Company by virtue of being a Director.

The Directors (other than Mr Grant Ferguson who has a material personal interest in the Resolution) consider that Shareholder approval pursuant to Chapter 2E of the Corporations Act is not required in respect of the issue because the agreement to issue the Performance Rights, reached as part of the remuneration package for Mr Grant Ferguson, is considered reasonable remuneration in the circumstances and was negotiated on an arm’s length basis.

7.3 Listing Rule 10.11

A summary of Listing Rule 10.11 is set out in Section 5.3 above.

The issue falls within Listing Rule 10.11.1 and does not fall within any of the exceptions in Listing Rule 10.12. It therefore requires the approval of Shareholders under Listing Rule 10.11.

7.4 Technical information required by Listing Rule 14.1A

If Resolution 8 is passed, the Company will be able to proceed with the issue within one month after the date of the Meeting (or such later date as permitted by any ASX waiver or modification of the Listing Rules). As approval pursuant to Listing Rule 7.1 is not required for the issue (because approval is being obtained under Listing Rule 10.11), the issue will not use up any of the Company’s 15% annual placement capacity.

If Resolution 8 is not passed, the Company will not be able to proceed with the issue.

13

7.5 Technical Information required by Listing Rule 10.13

REQUIRED INFORMATION DETAILS
Name of the person to whom
Securities will be issued
Mr Grant Ferguson (or his nominee(s)).
Categorisation under Listing
Rule 10.11
The recipient falls within the category set out in Listing Rule
10.11.1 as they are a related party of the Company by virtue
of being a Director.
Any nominee(s) of the recipient who receive Securities may
constitute ‘associates’ for the purposes of Listing Rule
10.11.4.
Number of Securities and
class to be issued
8,865,000 Performance Rights will be issued.
Terms of Securities The Performance Rights will be issued on the terms and
conditions set out in Schedule 2.
Date(s) on or by which the
Securities will be issued
The Company expects to issue the Performance Rights
within 5 Business Days of the Meeting. In any event, the
Company will not issue any Performance Rights later than
one month after the date of the Meeting (or such later date
to the extent permitted by any ASX waiver or modification
of the Listing Rules).
Price or other consideration
the Company will receive for
the Securities
The Performance Rights will be issued at a nil issue price.
Purpose of the issue,
including the intended use of
any funds raised by the issue
The purpose of the issue is to provide a performance linked
incentive component in the remuneration package for Mr
Grant Ferguson to motivate and reward their performance
as a Director and to provide cost effective remuneration to
Mr Grant Ferguson, enabling the Company to spend a
greater proportion of its cash reserves on its operations than
it would if alternative cash forms of remuneration were given
to Mr Grant Ferguson.
Remuneration package The current total remuneration package for Mr Grant
Ferguson is $306,625, comprising of a salary of $275,000, a
superannuation payment of $31,625 and share-based
payments as agreed by the Directors and subject to
Shareholder approval. If the Securities are issued, the total
remuneration package of Mr Grant Ferguson will increase
by $97,515 to $404,140, being the value of the Performance
Rights (based on the closing price of Shares as at the date
of this Notice).
Summary of material terms of
agreement to issue
The Securities were not issued under an agreement.
Voting exclusion statement A voting exclusion statement applies to this Resolution.
Voting prohibition statement A voting prohibition statement applies to this Resolution.

14

G L OS S A RY

$ means Australian dollars.

AEST means Australian Eastern Standard Time as observed in Sydney, New South Wales.

ASIC means the Australian Securities & Investments Commission.

ASX means ASX Limited (ACN 008 624 691) or the financial market operated by ASX Limited, as the context requires.

Board means the current board of directors of the Company.

Business Day means Monday to Friday inclusive, except New Year’s Day, Good Friday, Easter Monday, Christmas Day, Boxing Day, and any other day that ASX declares is not a business day.

Chair means the chair of the Meeting.

Closely Related Party of a member of the Key Management Personnel means:

  • (a) a spouse or child of the member;

  • (b) a child of the member’s spouse;

  • (c) a dependent of the member or the member’s spouse;

  • (d) anyone else who is one of the member’s family and may be expected to influence the member, or be influenced by the member, in the member’s dealing with the entity;

  • (e) a company the member controls; or

  • (f) a person prescribed by the Corporations Regulations 2001 (Cth) for the purposes of the definition of ‘closely related party’ in the Corporations Act.

Company means Aruma Resources Limited (ACN 141 335 364).

Constitution means the Company’s constitution.

Corporations Act means the Corporations Act 2001 (Cth).

Directors means the current directors of the Company.

Explanatory Statement means the explanatory statement accompanying the Notice.

GBA Capital has the meaning given in Section 1.2.

Key Management Personnel has the same meaning as in the accounting standards issued by the Australian Accounting Standards Board and means those persons having authority and responsibility for planning, directing and controlling the activities of the Company, or if the Company is part of a consolidated entity, of the consolidated entity, directly or indirectly, including any director (whether executive or otherwise) of the Company, or if the Company is part of a consolidated entity, of an entity within the consolidated group.

Lead Manager Options has the meaning given in Section 1.2.

Listing Rules means the Listing Rules of ASX.

Mandate has the meaning given in Section 1.2.

Material Person means a related party of the Company, member of the Key Management Personnel, substantial holder of the Company, adviser of the Company or associate of any of these parties.

Meeting means the meeting convened by the Notice.

Notice means this notice of meeting including the Explanatory Statement and the Proxy Form.

Option means an option to acquire a Share.

Participation has the meaning given in Section 5.1.

15

Performance Right means a right to acquire a Share subject to satisfaction of performance milestones.

Placement has the meaning given in Section 1.1.

Placement Options has the meaning given in Section 1.1.

Placement Shares has the meaning given in Section 1.1.

Proxy Form means the proxy form accompanying the Notice.

Resolutions means the resolutions set out in the Notice, or any one of them, as the context requires.

Section means a section of the Explanatory Statement.

Security means a Share, Option or Performance Right (as applicable).

Share means a fully paid ordinary share in the capital of the Company.

Shareholder means a registered holder of a Share.

Tranche 1 has the meaning given in Section 1.1.

Tranche 2 has the meaning given in Section 1.1.

WST means Western Standard Time as observed in Perth, Western Australia.

16

S CHE DU L E 1 – T E RMS AN D CON DIT IO N S O F PL A CE MEN T O PT ION S A N D L E A D MA NA G E R O PT ION S

1. Entitlement Each Option entitles the holder to subscribe for one Share upon exercise of
the Option.
2. Exercise Price Subject to paragraph 9, the amount payable upon exercise of each
Option will be $0.017 per Option (Exercise Price).
3. Expiry Date Each Option will expire at 5:00pm (WST) on 30 June 2028 (Expiry Date).
An Option not exercised before the Expiry Date will automatically lapse on
the Expiry Date
4. Exercise Period The Options are exercisable at any time on or prior to the Expiry Date
(Exercise Period).
5. Exercise Notice The Options may be exercised during the Exercise Period by notice in
writing to the Company in the manner specified on the Option certificate
(Exercise Notice) and payment of the Exercise Price for each Option being
exercised in Australian currency by electronic funds transfer or other means
of payment acceptable to the Company.
6. Exercise Date An Exercise Notice is only effective on and from the later of the date of
receipt of the Exercise Notice and the date of receipt of the payment of
the Exercise Price for each Option being exercised in cleared funds
(Exercise Date).
7. Timing of issue of
Shares on
exercise
Within five Business Days after the Exercise Date, the Company will:
(a)
issue the number of Shares required under these terms and
conditions in respect of the number of Options specified in the
Exercise Notice and for which cleared funds have been received
by the Company;
(b)
if required, give ASX a notice that complies with section
708A(5)(e) of the Corporations Act, or, if the Company is unable
to issue such a notice, lodge with ASIC a prospectus prepared in
accordance with the Corporations Act and do all such things
necessary to satisfy section 708A(11) of the Corporations Act to
ensure that an offer for sale of the Shares does not require
disclosure to investors; and
(c)
if admitted to the official list of ASX at the time, apply for official
quotation on ASX of Shares issued pursuant to the exercise of the
Options.
If a notice delivered under 7(b) for any reason is not effective to ensure
that an offer for sale of the Shares does not require disclosure to investors,
the Company must, no later than 20 Business Days after becoming aware
of such notice being ineffective, lodge with ASIC a prospectus prepared in
accordance with the Corporations Act and do all such things necessary to
satisfy section 708A(11) of the Corporations Act to ensure that an offer for
sale of the Shares does not require disclosure to investors.
8. Shares issued on
exercise
Shares issued on exercise of the Options rank equally with the then issued
shares of the Company.
9. Reorganisation If there is a reorganisation of the issued share capital of the Company
(including any subdivision, consolidation, reduction, return or cancellation
of such issued capital of the Company), the rights of the holder will be
changed to the extent necessary to comply with the ASX Listing Rules
applicable to a reorganisation of capital at the time of the reorganisation.
10. Participation in
new issues
There are no participation rights or entitlements inherent in the Options and
holders will not be entitled to participate in new issues of capital offered to
Shareholders during the currency of the Options without exercising the
Options.

17

11. Change in
exercise
price/Adjustment
for rights issue
An Option does not confer the right to a change in Exercise Price or a
change in the number of underlying securities over which the Option can
be exercised.
12. Transferability The Options are transferable subject to any restriction or escrow
arrangements imposed by ASX or under applicable Australian securities
laws.

18

S CHE DU L E 2 – T E RMS A N D CO N DIT ION S O F PE RFO RMA N CE RIG HT S

1. Entitlement Each Performance Right entitles the holder to subscribe for one Share
upon conversion of the Performance Right.
2. Consideration The Performance Rights will be issued for nil consideration, and no
consideration will be payable upon the conversion of the Performance
Rights into Shares.
3. Vesting Conditions/
Milestones
The Performance Rights shall vest as follows:
(a)
The Class A Performance Rights shall vest on;
(i)
a
Program
for
Environmental
Protection
and
Rehabilitation (PEPR) in respect of initial drilling
activities at the Wilan Project (EL 6819 & EL 6870), in
South Australia becomes approved; and
(ii)
the Company obtaining any and all necessary
approvals for the purposes of the relevant sections of
the_Mining Act 1971_(South Australia) to conduct initial
drilling activities.
(b)
The Class B Performance Rights shall vest on:
(i)
the Company announcing to the ASX an aggregate
drilling intercept in one drill-hole of at least 3m at
>600ppm U308or at least 20m at >0.8% Cu or metals
equivalent at one of the projects:
(A)
Fiery Creek (EPM 27879);
(B)
Bortala (EPM 28271); or
(C)
Wilan (EL 6819 & EL 6870); or
(ii)
the Company announcing to the ASX drilling
intercepts in two or more drill-holes of 2m at 3g/t Au
or metals equivalent from any one of the Company’s
projects.
(c)
The Class C Performance Rights shall vest upon the release of
an ASX announcement by the Company of the completion of
an acquisition of a material project which demonstrates
evidence, to the Board’s satisfaction acting reasonably, of
existing mineralisation supported by previous exploration results,
(each, aVesting Condition).
4. Expiry Date The Performance Rights whether vested or unvested, will otherwise expire
on the earlier to occur of:
(a)
the holder ceasing to be an officer (and employee, if
applicable) or an employee of the Company (where they are
not an officer at the time of issue), as applicable, unless
otherwise determined by the Board at its absolute discretion; or
(b)
5:00 pm (WST) on 1 August 2029,
(Expiry Date).
For the avoidance of doubt, any unconverted Performance Rights will
automatically lapse on the Expiry Date.
5. Notice of vesting The Company shall notify the holder in writing when the relevant Vesting
Condition has been satisfied.
6. Quotation of
Performance Rights
The Performance Rights will not be quoted on ASX.
7. Conversion Subject to paragraph 16, upon vesting, each Performance Right will, at
the election of the holder, convert into one Share.

19

8. Timing of issue of
Shares on conversion
Within five Business Days of conversion of the Performance Rights, the
Company will:
(a)
issue the number of Shares required under these terms and
conditions in respect of the number of Performance Rights
converted;
(b)
if required, give ASX a notice that complies with section
708A(5)(e) of the Corporations Act, or, if the Company is unable
to issue such a notice, lodge with ASIC a prospectus prepared
in accordance with the Corporations Act and do all such things
necessary to satisfy section 708A(11) of the Corporations Act to
ensure that an offer for sale of the Shares does not require
disclosure to investors; and
(c)
if admitted to the official list of ASX at the time, apply for official
quotation on ASX of Shares issued pursuant to the exercise of
the Performance Rights.
If a notice delivered under 7(b) for any reason is not effective to ensure
that an offer for sale of the Shares does not require disclosure to investors,
the Company must, no later than 20 Business Days after becoming aware
of such notice being ineffective, lodge with ASIC a prospectus prepared
in accordance with the Corporations Act and do all such things
necessary to satisfy section 708A(11) of the Corporations Act to ensure
that an offer for sale of the Shares does not require disclosure to investors.
9. Shares issued on
exercise
Shares issued on exercise of the Performance Rights rank equally with the
then issued shares of the Company.
10. Change of Control Subject to paragraph 16, upon:
(a)
a bona fide takeover bid under Chapter 6 of the Corporations
Act having been made in respect of the Company and:
(i)
having received acceptances for not less than 50.1%
of the Company’s Shares on issue; and
(ii)
having been declared unconditional by the bidder;
or
(b)
a court granting orders approving a compromise or
arrangement for the purposes of or in connection with a
scheme for the reconstruction of the Company or its
amalgamation with any other company or companies,
then, to the extent Performance Rights have not converted into Shares
due to satisfaction of the relevant Vesting Conditions, Performance Rights
will accelerate vesting conditions and will automatically convert into
Shares on a one-for-one basis.
11. Participation in new
issues
There are no participation rights or entitlements inherent in the
Performance Rights and holders will not be entitled to participate in new
issues of capital offered to Shareholders during the currency of the
Performance Rights without converting the Performance Rights.
12. Adjustment for bonus
issues of Shares
If the Company makes a bonus issue of Shares or other securities to the
Company’s existing shareholders (other than an issue in lieu or in
satisfaction of dividends or by way of dividend reinvestment no changes
will be made to the Performance Rights.
13. Reorganisation If at any time the issued capital of the Company is reorganised (including
consolidation, subdivision, reduction or return), all rights of a holder will be
changed in a manner consistent with the applicable ASX Listing Rules and
the Corporations Act at the time of reorganisation.
14. Dividend and voting
rights
The Performance Rights do not confer on the holder an entitlement to
vote (except as otherwise required by law) or receive dividends.
15. Transferability The Performance Rights are not transferable.

20

16. Deferral of
conversion if resulting
in a prohibited
acquisition of Shares
If the conversion of a Performance Right under paragraphs 7 or 10 would
result in any person being in contravention of section 606(1) of the
Corporations Act (General Prohibition) then the conversion of that
Performance Right shall be deferred until such later time or times that the
conversion would not result in a contravention of the General Prohibition.
In assessing whether a conversion of a Performance Right would result in
a contravention of the General Prohibition:
(a)
holders may give written notification to the Company if they
consider that the conversion of a Performance Right may result
in the contravention of the General Prohibition. The absence of
such written notification from the holder will entitle the
Company to assume the conversion of a Performance Right will
not result in any person being in contravention of the General
Prohibition; and
(b)
the Company may (but is not obliged to) by written notice to a
holder request a holder to provide the written notice referred to
in paragraph (n)(i) within 7 days if the Company considers that
the conversion of a Performance Right may result in a
contravention of the General Prohibition. The absence of such
written notification from the holder will entitle the Company to
assume the conversion of a Performance Right will not result in
any person being in contravention of the General Prohibition.
17. No rights to return of
capital
A Performance Right does not entitle the holder to a return of capital,
whether in a winding up, upon a reduction of capital or otherwise.
18. Rights on winding up A Performance Right does not entitle the holder to participate in the
surplus profits or assets of the Company upon winding up.
19. ASX Listing Rule
compliance
The Board reserves the right to amend any term of the Performance Rights
to ensure compliance with the ASX Listing Rules.
20. No other rights A Performance Right gives the holder no rights other than those expressly
provided by these terms and conditions and those provided at law where
such rights at law cannot be excluded by these terms.

21

for Securityholder registration.

ARUMA RESOURCES LIMITED | ABN 77 141 335 364

==> picture [169 x 58] intentionally omitted <==

Proxy Voting Form If you are attending the Meeting in person, please bring this with you

Your proxy voting instruction must be received by 10.15am (AEST) on Saturday, 14 June 2025 , being not later than 48 hours before the commencement of the Meeting. Any Proxy Voting instructions received after that time will not be valid for the scheduled Meeting.

SUBMIT YOUR PROXY

Complete the form overleaf in accordance with the instructions set out below.

YOUR NAME AND ADDRESS

The name and address shown above is as it appears on the Company’s share register. If this information is incorrect, and you have an Issuer Sponsored holding, you can update your address through the investor portal: https://investor.automic.com.au/#/home Shareholders sponsored by a broker should advise their broker of any changes.

STEP 1 – APPOINT A PROXY

If you wish to appoint someone other than the Chair of the Meeting as your proxy, please write the name of that Individual or body corporate. A proxy need not be a Shareholder of the Company. Otherwise if you leave this box blank, the Chair of the Meeting will be appointed as your proxy by default.

DEFAULT TO THE CHAIR OF THE MEETING

Any directed proxies that are not voted on a poll at the Meeting will default to the Chair of the Meeting, who is required to vote these proxies as directed. Any undirected proxies that default to the Chair of the Meeting will be voted according to the instructions set out in this Proxy Voting Form, including where the Resolutions are connected directly or indirectly with the remuneration of Key Management Personnel.

Lodging your Proxy Voting Form:

Online

Use your computer or smartphone to appoint a proxy at

https://investor.automic.com.au/#/loginsah or

scan the QR code below using your smartphone

Login & Click on ‘Meetings’. Use the Holder Number as shown at the top of this Proxy Voting Form.

==> picture [58 x 58] intentionally omitted <==

STEP 2 - VOTES ON ITEMS OF BUSINESS

You may direct your proxy how to vote by marking one of the boxes opposite each item of business. All your shares will be voted in accordance with such a direction unless you indicate only a portion of voting rights are to be voted on any item by inserting the percentage or number of shares you wish to vote in the appropriate box or boxes. If you do not mark any of the boxes on the items of business, your proxy may vote as he or she chooses. If you mark more than one box on an item your vote on that item will be invalid.

APPOINTMENT OF SECOND PROXY

You may appoint up to two proxies. If you appoint two proxies, you should complete two separate Proxy Voting Forms and specify the percentage or number each proxy may exercise. If you do not specify a percentage or number, each proxy may exercise half the votes. You must return both Proxy Voting Forms together. If you require an additional Proxy Voting Form, contact Automic Registry Services.

SIGNING INSTRUCTIONS

Individual: Where the holding is in one name, the Shareholder must sign. Joint holding: Where the holding is in more than one name, all Shareholders should sign. Power of attorney: If you have not already lodged the power of attorney with the registry, please attach a certified photocopy of the power of attorney to this Proxy Voting Form when you return it.

Companies: To be signed in accordance with your Constitution. Please sign in the appropriate box which indicates the office held by you.

Email Address: Please provide your email address in the space provided.

By providing your email address, you elect to receive all communications despatched by the Company electronically (where legally permissible) such as a Notice of Meeting, Proxy Voting Form and Annual Report via email.

CORPORATE REPRESENTATIVES

If a representative of the corporation is to attend the Meeting the appropriate ‘Appointment of Corporate Representative’ should be produced prior to admission. A form may be obtained from the Company’s share registry online at https://automicgroup.com.au.

BY MAIL:

Automic GPO Box 5193 Sydney NSW 2001

IN PERSON:

Automic Level 5, 126 Phillip Street Sydney NSW 2000

BY EMAIL:

[email protected]

BY FACSIMILE:

+61 2 8583 3040

All enquiries to Automic: WEBSITE:

https://automicgroup.com.au

PHONE:

1300 288 664 (Within Australia) +61 2 9698 5414 (Overseas)

STEP 1 - How to vote

APPOINT A PROXY:

I/We being a Shareholder entitled to attend and vote at the General Meeting of ARUMA RESOURCES LIMITED, to be held at 10.15am (AEST) on Monday, 16 June 2025 at Room 26L – Wynyard, Level 26 1 Bligh Street, SYDNEY NSW 2000 hereby:

==> picture [37 x 171] intentionally omitted <==

Appoint the Chair of the Meeting (Chair) OR if you are not appointing the Chair of the Meeting as your proxy, please write in the box provided below the name of the person or body corporate you are appointing as your proxy or failing the person so named or, if no person is named, the Chair, or the Chair’s nominee, to vote in accordance with the following directions, or, if no directions have been given, and subject to the relevant laws as the proxy sees fit and at any adjournment thereof. The Chair intends to vote undirected proxies in favour of all Resolutions in which the Chair is entitled to vote. Unless indicated otherwise by ticking the “for”, “against” or “abstain” box you will be authorising the Chair to vote in accordance with the Chair’s voting intention. AUTHORITY FOR CHAIR TO VOTE UNDIRECTED PROXIES ON REMUNERATION RELATED RESOLUTIONS Where I/we have appointed the Chair as my/our proxy (or where the Chair becomes my/our proxy by default), I/we expressly authorise the Chair to exercise my/our proxy on Resolution 8 (except where I/we have indicated a different voting intention below) even though Resolution 8 is connected directly or indirectly with the remuneration of a member of the Key Management Personnel, which includes the Chair.

AMPL
STEP 2 - Your voting direction
Resolutions
For
Against
Abstain
1
RATIFICATION OF PRIOR ISSUE OF TRANCHE 1 PLACEMENT SHARES – LISTING RULE 7.1
2
RATIFICATION OF PRIOR ISSUE OF TRANCHE 1 PLACEMENT SHARES – LISTING RULE 7.1A
3
APPROVAL TO ISSUE TRANCHE 2 PLACEMENT SHARES
4
APPROVAL TO ISSUE PLACEMENT OPTIONS
5
APPROVAL FOR DIRECTOR PARTICIPATION IN PLACEMENT – MR JAMES MOSES
6
APPROVAL FOR DIRECTOR PARTICIPATION IN PLACEMENT – MR BRETT SMITH
7
APPROVAL TO ISSUE OPTIONS TO GBA CAPITAL
8
APPROVAL TO ISSUE PERFORMANCE RIGHTS – MR GRANT FERGUSON
Please note:If you mark the abstain box for a particular Resolution, you are directing your proxy not to vote on that Resolution on a show of hands or on
a poll and your votes will not be counted in computing the required majority on a poll.
S
STEP 3 – Signatures and contact details
Individual or Securityholder 1
Securityholder 2
Securityholder 3
Sole Director and Sole Company Secretary
Director
Director / Company Secretary
Contact Name:
Email Address:
S
STEP 3 – Signatures and contact details
Individual or Securityholder 1
Securityholder 2
Securityholder 3
Sole Director and Sole Company Secretary
Director
Director / Company Secretary
Contact Name:
Email Address:
S
STEP 3 – Signatures and contact details
Individual or Securityholder 1
Securityholder 2
Securityholder 3
Sole Director and Sole Company Secretary
Director
Director / Company Secretary
Contact Name:
Email Address:
Contact Daytime Telephone
Date (DD/MM/YY)
/
/
By providing your email address, you elect to receive all communications despatched by the Company electronically (where legally permissible).